Generation of a TSC2 knockout embryonic stem cell line by CRISPR/ Cas9 editing

被引：0
|
作者：
Zhang, Siyao [1 ,2 ]
Fan, Jiaqi [1 ,2 ]
Sun, Hairui [1 ,2 ]
Hao, Xiaoyan [1 ,2 ]
He, Yihua [2 ]
机构：
[1] Capital Med Univ, Anzhen Hosp, Beijing 100029, Peoples R China
[2] Capital Med Univ, Beijing Anzhen Hosp, Maternal Fetal Med Ctr Fetal Heart Dis, Beijing 100029, Peoples R China
来源：
STEM CELL RESEARCH | 2024年 / 77卷
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1016/j.scr.2024.103399
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
Tuberous Sclerosis Complex (TSC) is a severe developmental disorder with various clinical effects, primarily caused by TSC2 gene mutations, often involving loss of function(Henske,et al., 2016).To explore role of TSC2 in human heart development, we successfully developed a TSC2 knockout (TSC2-/-) human embryonic stem cells (hESCs) line using CRISPR/Cas9 gene editing. This TSC2-/- hESC line maintained a normal karyotype, expressed pluripotency markers strongly, and could differentiate into all three germ layers in vivo. This cell line will be a valuable tool for future research on the role of TSC2 in heart development.
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Generation of a TLR2 knockout human induced pluripotent stem cell line using CRISPR/Cas9
    Han, Hyeong-Jun
    Kim, Jung-Hyun
    STEM CELL RESEARCH, 2021, 57
  • [32] Generation of a GDE heterozygous mutation human embryonic stem cell line WAe001-A-14 by CRISPR/Cas9 editing
    Xu, Guosheng
    Guo, Dongsheng
    Wu, Feima
    Abbas, Nasir
    Lai, Keyu
    Yuan, Fang
    You, Kai
    Liu, Yanli
    Zhuang, Yuanqi
    Wu, Yuhang
    Xu, Yingying
    Chen, Yan
    Yang, Fan
    Pan, Tingcai
    Li, Yin-xiong
    STEM CELL RESEARCH, 2018, 27 : 38 - 41
  • [33] Generation of two RNF2 homozygous knockout human embryonic stem cell lines by CRISPR/Cas9 system
    Shan, Yongli
    Ma, Lishi
    Zhang, Cong
    Zhang, Yanqi
    Zhang, Jingyuan
    Xiao, Lu
    Wei, Yanxing
    Yu, Yanhong
    STEM CELL RESEARCH, 2020, 47
  • [34] Generation of a homozygous LRP2 knockout human embryonic stem cell line (FDCHDPe010-A-56) by CRISPR/Cas9 system
    You, Jie
    Cheng, Yun
    Yang, Xian-Jie
    Chen, Ling
    STEM CELL RESEARCH, 2021, 53
  • [35] Generation of SHMT2 knockout human embryonic stem cell line (WAe009-A-67) using CRISPR/Cas9 technique
    Li, Jisheng
    Zhang, Bowen
    Gan, Min
    Li, Yunxing
    He, Lijuan
    Yue, Wen
    Qiao, Haixuan
    Pei, Xuetao
    Li, Yanhua
    STEM CELL RESEARCH, 2021, 57
  • [36] Generation of a MIR5004 knockout cell line from human induced pluripotent stem cells by CRISPR/Cas9 gene editing
    Gulimiheranmu, Maisumu
    Li, Shuang
    Zhou, Junmei
    STEM CELL RESEARCH, 2022, 62
  • [37] Generation of an NSD2-deficient human embryonic stem cell line using CRISPR/Cas9 technology
    Zhao, Kui
    Zhang, Hanyue
    Cui, Jiaqi
    Zhang, Yanqi
    Zhou, Tiancheng
    Long, Bing
    STEM CELL RESEARCH, 2023, 73
  • [38] Generation of a Foxc2 Gene Knockout Murine Melanoma Cell Line via CRISPR Cas9 Genome Editing Technology
    Thompson, Jefferson
    Hargadon, Kristian
    FASEB JOURNAL, 2016, 30
  • [39] Generation of two ERF gene knockout human embryonic stem cell lines using CRISPR/Cas9 system
    Si, Lihui
    Yang, Ruiqi
    Liu, Jian
    Dong, Yubo
    Zhang, Hongtao
    Xu, Xiaohong
    STEM CELL RESEARCH, 2019, 41
  • [40] Construction of TSC2 knockout cell line using CRISPR/Cas9 system and demonstration of its effects on NIH-3T3 cells
    Wang, Xu
    Zhao, Yang
    Wang, Zhan
    Liao, Zhangcheng
    Zhang, Yushi
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2022, 80 (04) : 681 - 687
12345